| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.012 | 0.9 |